drugset / Trial / NCT02997982
Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease
NaSingle-groupOpen-labelTreatment
Summary
This study investigates the effects of Valaciclovir treatment to individuals with Alzheimer's disease or Mild Cognitive Impairment of Alzheimer's Disease Type. It is an open pilot trial where 36 participants will receive 4 weeks of Valaciclovir treatment. Participants will be investigated using different measures before and after the treatment period.
Timeline
- Start
- 2016-12
- Primary completion
- 2020-03-04
- Completion
- 2020-03-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valaciclovir | Unknown | 1000 mg | Oral |